Sana Biotechnology Inc (SANA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2026 | 12-2025 | 09-2025 | 06-2025 | 03-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -47,210 | -244,166 | -185,341 | -143,189 | -49,389 |
| Depreciation Amortization | 2,391 | 12,750 | 9,697 | 6,506 | 3,649 |
| Accounts payable and accrued liabilities | 454 | -3,545 | -3,356 | -2,999 | -4,224 |
| Other Working Capital | -6,508 | -10,114 | -13,528 | -14,225 | -10,858 |
| Other Operating Activity | 13,494 | 101,247 | 81,341 | 72,149 | 12,165 |
| Operating Cash Flow | $-37,379 | $-143,828 | $-111,187 | $-81,758 | $-48,657 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -40 | 494 | 706 | 611 | 117 |
| Purchase Of Investment | -5,588 | -87,293 | -51,209 | -1,682 | -1,682 |
| Sale Of Investment | 55,065 | 46,561 | 26,761 | 25,354 | 18,168 |
| Investing Cash Flow | $49,437 | $-40,238 | $-23,742 | $24,283 | $16,603 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | -91 | -347 | -258 | -171 | -85 |
| Common Stock Issued | -37 | 129,080 | 111,341 | 1,714 | 1,067 |
| Financing Cash Flow | $-128 | $128,733 | $111,083 | $1,543 | $982 |
| Beginning Cash Position | 76,065 | 131,398 | 131,398 | 131,398 | 131,398 |
| End Cash Position | 87,995 | 76,065 | 107,552 | 75,466 | 100,326 |
| Net Cash Flow | $11,930 | $-55,333 | $-23,846 | $-55,932 | $-31,072 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,379 | -143,828 | -111,187 | -81,758 | -48,657 |
| Capital Expenditure | -288 | -938 | -65 | -24 | -136 |
| Free Cash Flow | -37,667 | -144,766 | -111,252 | -81,782 | -48,793 |